Presentation TCT 2024

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

Presenter: Lei Song

October 29, 2024

REGISTER for free or LOG IN to view this content

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

Coronary

TCT 2024

DES/BRS/DCB

Up Next

Presentation TCT 2024

TCT 1364: A Case of Very Late Stent Thrombosis 7 Years After Drug-Eluting Stent Implantation

Presenter: Masaya Kusuda

October 29, 2024

More slides +

Presentation TCT 2024

TCT 1292: Recurrent Very Late Stent Thrombosis Due to Multiple Interstruts Hollows After First-Generation Sirolimus-Eluting Stent Implantation

Presenter: Takayuki Ishihara

October 29, 2024

Presentation TCT 2024

TCT 644: Burden of Non-Rheumatic Calcific Aortic Valve Disease and Non-Rheumatic Degenerative Mitral Valve Disease in High-Income North America and West Europe From 1990 to 2021

Presenter: Vidit Majmundar

October 29, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.